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ABSTRACT
Inﬂuenza A viruses (IAV) are highly contagious patho-
gens causing dreadful losses to human and animal,
around the globe. IAVs ﬁrst interact with the host
through epithelial cells, and the viral RNA containing a
5′-triphosphate group is thought to be the critical trigger
for activation of effective innate immunity via pattern
recognition receptors-dependent signaling pathways.
These induced immune responses establish the antiviral
state of the host for effective suppression of viral repli-
cation and enhancing viral clearance. However, IAVs
have evolved a variety of mechanisms by which they
can invade host cells, circumvent the host immune
responses, and use the machineries of host cells to
synthesize and transport their own components, which
help them to establish a successful infection and repli-
cation. In this review, we will highlight the molecular
mechanisms of how IAV infection stimulates the host
innate immune system and strategies by which IAV
evades host responses.
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INTRODUCTION
Inﬂuenza A viruses (IAV) cause highly pathogenic respira-
tory problems in human and animals. It is the major cause of
annual epidemics and occasional pandemics in humans,
responsible for 3–5 million cases of severe clinical infections
and 250,000 to 500,000 fatal cases every year throughout
the world (Stohr, 2002). Infection with inﬂuenza virus varies
from subclinical infection of upper respiratory tract to lethal
infection of lower respiratory system. Due to differences in
pathogenesis of various inﬂuenza viruses, biology of the
disease is not fully understood. Inﬂuenza virus infection
induces host innate immune responses, which results in the
termination of virus replication. On the other hand, IAV has
evolved multiple strategies to circumvent the host innate
immunity to establish a successful infection and replication.
In addition to typical seasonal infections, IAV can also
undergo substantial changes (recombination/antigenic shift)
that leave imprints of infection with little to no protective
immunity and uplift mortality rate even among healthy young
adults infected with IAV (Horimoto and Kawaoka, 2001;
Palese, 2004). Only, the last century we have observed three
major pandemics: the 1918 Spanish ﬂu, 1957 Asian ﬂu, and
the 1968 Hong Kong ﬂu; with the 1918 pandemic being the
most concerning and signiﬁcant, causing an estimated
30–50 million deaths worldwide (Horimoto and Kawaoka,
2001, 2005). Furthermore, the recent appearance of IAV
strains with pandemic potential, such as H1N1 “swine ﬂu”
and H5N1 avian inﬂuenza, have highlighted the importance
of studies about IAV infections and the innate and adaptive
immune responses that control and eliminate infection.
Thus, this review will focus on discussion of host innate
immune responses to IAV infection and viral escape from the
innate sensing.
BIOLOGY AND STRUCTURE OF IAV
Inﬂuenza viruses are categorized in the family of
Orthomyxoviridae. The virus particle is enveloped and con-
tains a segmented, single-stranded, negative sense RNA
genome (Klenk et al., 2004). Its genome possesses eight
segments encoding 13 proteins (Jagger et al., 2012), out of
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which 8 are considered core proteins whereas the rest are
called accessory proteins. Additionally, a putative open
reading frame (ORF) in the positive-sense of segment 8 has
been identiﬁed, which encodes for a hypothetical negative
sense protein (NSP) of ∼25 kDa (Zhirnov et al., 2007).
However, the role of NSP still remains elusive. Another
protein encoded within segment 2 (in addition to PB1 and
PB1-F2) has been identiﬁed, termed N40 (Wise et al., 2009).
Morphologically, the viral particles are creased with a lipid
bilayer, which is derived from the host plasma membrane.
The lipid bilayer contains almost 500 spikes (each of
10–14 nm), of viral proteins hemagglutinin (HA) and neu-
raminidase (NA), protruded out from the envelope. These
spikes appear as either rod-shaped (HA) or mushroom
shaped (NA). The ratio of HA to NA generally varies from 4:1
to 5:1. The high density of HA is probable to enhance the
chances for viral attachment. Additionally, matrix protein 2
(M2) is also enriched into the lipid envelope. The ratio
between M2 and HA is usually about 1:10 to 1:100 (Zebedee
and Lamb, 1988). Envelope viral glycoproteins (HA and NA)
have stumpy kinesis within envelope. These two proteins
fortify the viral structure by association with underlying matrix
protein 1 (M1), the most abundant envelop viral protein. M1
is associated with the viral ribonucleoproteins (vRNPs), core
of the virion and links to envelop glycoproteins to support the
viral particle structurally (Schaap et al., 2012)
The vRNPs is the stable lipid-free core within the virion.
The vRNP appears as ﬂexible rods in thin sectioning of the
virus. Structurally, vRNPs look like a twin-stranded helix, in
which vRNPs illustrate loop at one end and a bend at other.
The strand seems to be folded back on it and then coiled on
itself, to form a type of twin-stranded helix (Krug and Lamb,
2001). The core of vRNPs is comprised of 8 segmented RNA
coated by predominant viral protein, nucleoprotein (NP)
(Coloma et al., 2009; Fournier et al., 2012). The protein
coated fragments are also associated to the heterotrimeric
RNA dependent RNA polymerase subunits polymerase
basic 1, polymerase basic 2, and polymerase acidic (PB1,
PB2, PA) which is responsible for the viral genome replica-
tion and transcription both (Klumpp et al., 1997). These
polymerases are present at only 30 to 60 copies per virion
(Inglis et al., 1976; Krug and Lamb, 2001; Lamb and Chop-
pin, 1976).
VIRAL ATTACHMENT AND ENTRANCE
Innate immunity is formed by physical barriers (e.g., mucus
and collectins) and innate immune responses (Holt et al.,
2008). IAV infects the host by gaining access through the
nose, mouth or mucosal surfaces of the respiratory tract. To
initiate an infection, IAV must get access to columnar
epithelial cells of respiratory tract. Epithelial cells produce a
mucus layer to protect the respiratory tract from viral infec-
tion. Mucin and sialic acid compound line the epithelial cells,
which are cleaved by viral envelop glycoprotein NA. The
second envelop glycoprotein HA helps the virus to attach the
exposed epithelial cells by binding with sialic acid. The type
of sialic acid linkage to HA glycoprotein was considered to
be primary element in host tropism (Hamilton et al., 2012).
Human seasonal viruses almost exclusively attach to
N-acetylneuraminic (sialic) acid receptors at α-2,6 linkage,
whereas avian inﬂuenza viruses predominantly bind to α-2,3
sialic acid linkage. Owing to having both α-2,3 and α-2,6
linkages, pigs and several avian species (pheasants, tur-
keys, quails) may act as mixing vessels and can generate
reassortant viruses (Medina and Garcia-Sastre, 2011).
Recently, an alternative substrate C type lectin for the
binding of HA has been studied, an alternate of sialic acid
attachment (Upham et al., 2010). Viral attachment to the
surface of host cell induces viral uptake by endocytosis,
which utilizes the clatherin and clavoline dependent mech-
anism (Leung et al., 2012). After endocytosis, release of viral
particle is pH dependent physiological event that occurs at
late lysosome (Fontana et al., 2012). The acidity (pH
4.5–5.5) of the lysosome is crucial for the uncoating and
subsequent release of viral RNPs (Krug and Lamb, 2001;
Krug and Lamb 2001, 2006). The low pH cleaves the
association between the viral M1 and RNP complex to free
the viral RNA that is then imported via interaction with the
cellular importin-α/β (Flint SJ, 2003; O’Neill et al., 1995;
Whittaker and Digard, 2006).
IAV INFECTION AND INVOLVED PATTERN
RECOGNITION RECEPTORS
Onset of IAV infection is very acute by triggering a cascade
of immune responses and switching on almost all parts of
the immune defense system. Innate immune system orga-
nizes the ﬁrst line of defense against the viral infection,
which is quicker in response but lacks memory and speci-
ﬁcity. Most of the initial innate immune response is release of
cytokine such as interferon α/β (IFN α/β), invasion of alveolar
dendritic cells and macrophages (Achdout et al., 2003;
Mandelboim et al., 2001). Acute surge of cytokine release
leads to the inﬂammation response, which is responsible for
the acute onset of the clinical symptoms. Alveolar epithelial
cells have been naturally equipped with receptors to sense
presence of the viral RNA and very effectively initiate cellular
signaling pathways to clear viral infection. These cellular
receptors are categorized to several families of pattern
recognition receptors (PRRs). PRRs sense the viral RNA
and activate downstream signaling pathways (Bleiblo et al.,
2012). Toll like receptors (TLRs), retinoic acid inducible
gene-I (RIG-I), and nucleotide-binding oligomerization
domain (NOD) like receptors (NLRs) are three key families of
PRRs (Pang and Iwasaki, 2011) involved in sensing viral
infection.
Toll like receptors
TLRs form a major group of transmembrane receptors that
are involved in the detection of viral nucleic acids (Kawai and
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Akira, 2011). TLRs can sense the infection of RNA viruses,
TLR7 binds with the ssRNA derived from viruses like inﬂu-
enza virus and TLR3 senses dsRNAs (Guillot et al., 2005;
Lund et al., 2004). Binding of RNA with TLRs activates the
production of pro-inﬂammatory cytokines, chemokines, and
IFN signaling pathways with the help of intracellular adaptors
(Alexopoulou et al., 2001). Upon activation, TLR7 interacts
with the adaptor protein myeloid differentiation factor 88
(MyD88) in plasmacytoid dendritic cells (DCs), leading to the
activation of IRF7 and NF-κB that control the high levels of
IFNβ and IFNα transcription (Lund et al., 2004). Similarly,
TLR3 interacts with TRIF in macrophages and DCs, and
TRIF activates the serine-threonine kinases IκKε (IKKε) and
TBK1, resulting in phosphorylation of the transcription factor
IRF3. Then IRF3 enters the nucleus and induces the
expression of IFNβ (Fig. 1). Although it is well known that
inﬂuenza virus activates both TLR3 and TLR7 pathways (Le
Gofﬁc et al., 2007), either activation of TLR3 or TRL7 alone
could not elucidate the IFN-mediated antiviral defense dur-
ing infection. In addition, TLR8 is stimulated by the ligand of
ssRNA and its activation results in the production of IL-12
but not IFNα. However, the role of TLR8 in IAV infection is
poorly understood (Ablasser et al., 2009). Recently, it has
been shown that TLR10 may also play an important role in
innate immune response to IAV infection and signaling via
TLR10 is triggered by the active RNA-protein complex of
inﬂuenza virus (Lee et al., 2014). However, the molecular
mechanisms underlying function of these TLRs in IAV-in-
duced innate immunity remain to be fully understood.
RIG like receptors
RIG-I is the key receptor involved in the intracellular detec-
tion of inﬂuenza viral ssRNA during the IAV infection (Loo
et al., 2008). In addition to detection of ssRNA, RIG-I and
MDA5 (melanoma differentiation-associated gene 5) play a
critical role by recognizing the vRNP and transcriptional
intermediates containing 5′-triphosphate produced during
the viral replication (Pichlmair et al., 2006). Upon sensing the
viral ssRNA or transcriptional intermediates, RIG-I initiates a
process that makes conformational changes to expose
caspase activation and recruitment domains (CARDs).
These domains are ubiquitinated by the action of E3 ligases
such as TRIM25 (Munir, 2010). RIG-I can then associate
with mitochondrial antiviral signaling adaptor (MAVS; also
known as IPS-1, VISA or Cardif), and leads to the activation


































Figure 1. Activation of host innate immune response and function of inﬂuenza viral NS1 protein as an antagonist. The virus
and its nucleic acid are sensed by the RIG-I or TLR, which leads to activation of IRF3, NF-kB, and AP-1 transcription factors. These
transcription factors bind to their respective putative binding sites and initiate the transcription of type I IFN, which activates auto- or
paracrine pathways to initiate the antiviral responses. However, IAV NS1 protein is able to interact with different components involved
in the IFN-mediated immune responses and thereby inhibits these responses.
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activation of IRF and NF-κB signaling have been extensively
reviewed (Kawai and Akira, 2011; Loo and Gale, 2011).
NOD like receptors
The NLRs are cytosolic pattern-recognition receptors, which
form a multiprotein inﬂammasome complex consisting of
NLRP, the adaptor ASC, and procaspase. NLRP3 is acti-
vated by membrane damage, inﬂammation or stress such as
infection with pathogens (Martinon et al., 2009). Activation of
inﬂammasomes results in the change of procaspase I to its
active form caspase 1 by autocatalytic process (Bergsbaken
et al., 2009), which contributes to production of active form of
IL-1β and IL-18. NLRP3 is expressed in various cells
including neutrophils, monocytes, DCs, macrophages, and
human bronchial epithelial cells (Guarda et al., 2011; Poth-
lichet et al., 2013). Two signals are required to trigger cyto-
kine production by the inﬂammasome. Signal 1 is dependent
on TLR, IL-1 receptor (IL-1R), and TNFR signaling pathway,
which activates the expression of the genes encoding
pro-IL-1β, pro-IL-18, and NLRP3 (Martinon et al., 2009).
Signal 2 is induced by host damage, which causes the
activation of caspase 1 that is required for the secretion of
mature IL-1β and IL-18.
Three inﬂuenza virus-associated stimuli cause the
secretion of IL-1β and IL-18. First response is against
ssRNA from inﬂuenza virus, which is adequate to activate
the release of IL-1β from particular cell types (Thomas et al.,
2009). Secondly, the inﬂuenza virus-encoded M2 ion chan-
nel in the trans-Golgi network causes the proton ﬂux that can
inhibit the activation of HA, which elicits NLRP3 activation
and leads to the formation of the inﬂammasome and cleav-
age of pro-IL-1β and pro-IL-18 (Ichinohe et al., 2010). Third
stimulus is the aggregation of inﬂuenza virus virulent protein
PB1-F2 in the lysosome of lipopolysaccharide primed mac-
rophages, leading to activation of the NLRP3 inﬂammasome
(McAuley et al., 2013).
ACTIVATION AND REGULATION OF HOST INNATE
IMMUNE RESPONSES DURING IAV INFECTION
During inactive phase, NF-κB, IRF3/7, and c-jun/ATF-2
(AP-1) are remained in the cytoplasm. PRR sensing IAV
infection causes activation of IRF3/7 through phosphoryla-
tion of the C-terminus of IRF3/7 and dimerization that leads
to the exposure of nuclear localization signal (NLS), which in
turn results in nuclear translocation of IRF3/7. On the other
hand, the inhibitor of NF-κB (IκB) retains the NF-κB in the
cytoplasm. IκB undergoes ubiquitination and proteasomal
degradation upon sensing of appropriate signals by PRR.
Removal of IκB leads to nuclear translocation of NF-κB via
its NLS (Hayden and Ghosh, 2004). Phosphorylation of c-jun
and ATF-2, two heterodimeric components of AP-1, also play
their role in nuclear translocation of NF-κB. In the nucleus,
these transcription factors assemble in an accommodating
manner to make an enhanceosome, which binds to its
respective positive regulatory domains (PRDs). The IRF3/
IRF7, NF-κB, and AP-1 bind to PRD I/III, PRD II, and PRD IV,
respectively, where they promote the transcription of IFN-α,
IFN-β, and pro-inﬂammatory cytokines (TNF, IL6, IL1β, etc.).
Following production, IFN-α and IFN-β mediate a positive
feedback-production loop by binding to the IFN-α/β receptor
(IFNAR) in an auto- and/or paracrine manner. Receptor-
mediated activation of Janus kinase-signal transducer and
activator of transcription (JAK-STAT) signaling results in the
recruitment and phosphorylation of IRF9 into the STAT1/
STAT2 heterodimer, to make interferon-stimulated gene
factor 3 (ISGF3) (Mukaigawa and Nayak, 1991). Upon for-
mation and nuclear localization of ISGF3, it binds to inter-
feron-stimulated response elements (ISREs) (Kessler et al.,
1990), which consequently leads to the transcription of
hundreds of IFN stimulated genes (ISGs). These ISGs act as
innate immune defense against the viral infection.
However, numerous protein phosphatases, regulatory
RNA, and the suppressors of cytokine signaling (SOCS) like
SOCS1 and SOCS3 are found to be involved in negative
regulation of JAK-STAT pathway (Yasukawa et al., 1999).
Recently, it has been shown that inﬂuenza virus-induced
SOCS1 is independent of cytokine at early stages of infec-
tion both in vitro and in vivo, remarkably suppresses the
activation of STAT1. This process leads to the suppression
of IFN-λ-activated signaling during IAV infection. Suppres-
sion of IFN-λ response by increased level of SOCS1 acti-
vates the NF-κB signaling, which is an adaptation of host to
protect cell against the viral induced SOCS1 (Wei et al.,
2014). Activation of NF-κB leads to increased production of
IFN-λ during IAV infection.
Long noncoding RNAs (lncRNAs) are an important class
of regulatory RNAs in a variety of cellular processes.
Recently, it has been shown that a human lncRNA named
NRAV (Negative Regulator of Anti-Viral response) normally
expressed in various human cells plays an important regu-
latory role in host innate immunity. Upon infection with IAV,
ssRNA virus (SeV), dsRNA virus (MDRV) or DNA virus
(HSV), down regulation of NRAV was observed. Further
investigations revealed that NRAV is critically involved in
regulation of IAV pathogenesis, as evidenced by consider-
ably higher virulence, enhanced acute lung injury and con-
sequently decreased survival rates of transgenic mice
overexpressing the lncRNA NRAV when compared with wild
type mice. Particularly, mRNA levels of some critical ISGs
were substantially reduced in NRAV-overexpressing cells
and transgenic (TG) mice infected with IAV, including IFIT2,
IFIT3, IFITM3, OASL, and MxA. These studies suggest that
NRAV is a key negative regulator of some ISGs during IAV
infection in vitro and in vivo. Therefore, down regulation of
NRAV in IAV-infected cells might be a host self-protection
response to the virus infection, which may be critical for viral
clearance (Ouyang et al., 2014). Because these ISGs play
crucial roles in a wide range of immune responses, including
immunity against invading pathogens, providing an
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antagonistic environment to limit virus propagation and
spread, as well as transcriptional and translational regulation
of other antiviral genes (de Veer et al., 2001), further studies
are required to determine the importance of NRAV in these
cellular processes.
CELLS CRITICALLY INVOLVED IN INNATE
IMMUNITY AGAINST IAV INFECTION
Infection of inﬂuenza virus in epithelial cells induces
expression of many inﬂammatory cytokines and chemokines,
such as IL-1β, IL-6, IL-8 TNF-α, CCL2, CCL3, and CXCL10
(Perrone et al., 2008). During early stages of IAV infection,
CCL2 attracts alveolar macrophages and monocytes via their
CCR2 receptors and activates the macrophages (Dawson
et al., 2000; Herold et al., 2006; Lin et al., 2008). Once
macrophages are activated during IAV infection of lungs, they
produce nitric oxide synthase (NOS2) and tumor necrosis
alpha (TNFα), which lead to the IAV-induced pathologic
response (Jayasekera et al., 2006; Lin et al., 2008). The two
discrete functions by activated macrophages upon IAV
infection are very crucial for balanced responses against the
viral infection. Once activated, macrophages enhance their
pro-inﬂammatory cytokine response, including production of
IFNs, IL-6, and TNF-α (Becker et al., 1991; van Riel et al.,
2011). In addition, infection by inﬂuenza virus triggers acti-
vation of the alveolar macrophages that phagocytose infec-
ted cells (Kim et al., 2008). Thus, alveolar macrophages play
a direct role in limiting viral spread by phagocytosis of
apoptotic-infected cells and by phagocyte-mediated
opsonophagocytosis of inﬂuenza virus particles (Hashimoto
et al., 2007; Kim et al., 2008; Tumpey et al., 2005).
Natural killer (NK) cells are important cytotoxic and
effector cells of innate immunity that serve as a crucial ﬁrst-
line defense against tumors and virus-infected cells. It has
been previously shown that lysis of IAV-infected cells is
mediated by the interaction between the NK receptors,
NKp44 and PKp46, and the IAV hemagglutinin (HA) type 1
expressed by the infected cells (Mendelson et al., 2010).
Cells infected with IAV express HA protein on their surface
that is important for recognition by NK cells via their recep-
tors (Mendelson et al., 2010). Association of NK cells with
IAV-infected cells initiates the lysis of the target cells (Arnon
et al., 2001). It has been shown that mice lacking the NKp46
receptor equivalent, NCR-1, displayed increased morbidity
and mortality following inﬂuenza virus infection (Gazit et al.,
2006). In addition, natural killer T (NKT) cells are known as a
distinct lymphocyte lineage that regulates an expansive
range of immunity. As innate immune cells, NKTcells can be
activated during inﬂammation and viral infection. It has been
suggested that NKT cells enhance the cellular immunity and
regulate the pathogenesis mediated by IAV infection (Paget
et al., 2011). However, many questions still remain unan-
swered regarding the function of NK cells and NKT cells
during the IAV infection, including how these cells trafﬁc to
IAV-infected lung, their cellular dynamics, and mechanisms
underlying their immunoregulatory functions.
IAV EVASION FROM INNATE IMMUNITY
Although the host innate immune system has stout antiviral
activity, it is inept in many cases to prevent inﬂuenza virus
infections. This is due to the fact that inﬂuenza virus, as
many other successful viruses, has evolved strategies to
escape the immune response to levels that provide space for
replication and transmission within their hosts. Interestingly,
inﬂuenza virus uses multiple mechanisms to evade and
inhibit the innate immune response of the host. On the other
hand, a high immune and antiviral drug pressure in the host
population pushes the inﬂuenza virus to mutate rapidly to
generate new strains of IAV. The escape mechanisms by
inﬂuenza viral proteins are discussed here.
Non-structural protein 1
IAV has evolved multiple mechanisms to use its non-struc-
tural protein 1 (NS1) to mitigate the host innate immune
response to inﬂuenza virus infection. NS1 is considered
being the most important IFN-antagonist protein encoded by
the inﬂuenza virus. This protein is highly expressed in the
cytoplasm and the nucleus of infected cells where it is able to
interact with different components involved in the IFN-me-
diated immune responses and thereby inhibits these
responses (Hale et al., 2010). NS1 protein contains RNA
binding domain located in ﬁrst 73 amino-terminal amino
acids that can bind with viral RNA and prevent it to be rec-
ognized by TLRs and RIG-I. Using reverse genetics tech-
niques, it was observed that inﬂuenza viruses lacking or
carrying the truncated NS1 gene induced increased IFN
secretion from infected cells in vivo and in vitro (Ferko et al.,
2004; Garcia-Sastre et al., 1998; Solorzano et al., 2005;
Steel et al., 2009).
Cellular proteins like RIG-I, PKR, and OAS are activated
by sensing dsRNA. However, the NS1 protein competes with
these proteins for RNA binding and thereby deteriorates their
activation. As OAS is less fascinating for dsRNA as com-
pared to PKR and RIG-I, the NS1 can inhibit OAS activation
precisely by binding with dsRNA (Li et al., 2006). Interest-
ingly, NS1 protein of IAV impairs activity of RIG-I and PKR
through suppressing E3 ubiquitin ligase TRIM25 that is
required for posttranslational modiﬁcation of RIG-I and acti-
vation of its signaling cascade including IRF-3, NF-κB, and
ATF-2/c-Jun, or by direct binding with PKR (Gack et al.,
2009; Gack et al., 2007; Li et al., 2006). Additionally, NS1
protein inhibits the processing of cellular mRNA in the
nucleus by binding with the cellular factor CPSF30 and
PABPII that are involved in transcriptional termination and
polyadenylation (Chen et al., 1999; Nemeroff et al., 1998).
NS1 can also interact with splicing and nuclear export factors
(Satterly et al., 2007). The general inhibition of gene
expression by inhibition of mRNA processing not only
REVIEW Mohsan Ullah Goraya et al.









prevents efﬁcient IFN expression but also suppresses the
activation of ISGs. Moreover, NS1 was found to interact with
a eukaryotic translation initiation factor family member eIF4B
that is a key component of regulation of mRNA translation
initiation. Recently, it has been revealed that inﬂuenza virus
NS1 induces the degradation of the eIF4B protein (Fig. 1).
Silencing of eIF4B signiﬁcantly reduced the protein expres-
sion of interferon-induced transmembrane protein 3
(IFITM3), a critical protein involved in immune defense
against a variety of RNA viruses via constraining the viral
entry and consequently blocking the early stages of viral
replication of IAV (Wang et al., 2014). Transgenic eIF4B
knockdown mice infected with inﬂuenza virus showed high
mortality as compared to wild type mice. It was also
observed that eIF4B knockdown mice showed decreased
amount of IFITM3 and high mortality by inﬂuenza virus
infection compared with wild type mice (Wang et al., 2014).
Besides inhibition of IFN response, NS1 plays several other
roles during viral infection. However, other functions of NS1
are still unclear, suggesting it to be an exciting area of
research in the near future.
Polymerase complex
Viral proteins PB1, PB2 and PA form the inﬂuenza poly-
merase complex that controls the synthesis of viral RNA and
mRNA. In addition, it is also involved in cap-snatching of host
mRNAs and consequently reduces host cell gene expression
including that of IFN-β (Dias et al., 2009). PB1 gene encodes
a polypeptide of almost 80 amino acids, with speciﬁc poly-
morphism and has been implicated in virulence of virus with
speciﬁc polymorphism (Chen et al., 2001). PB1-F2 with a
serine at position 66 can interact with MAVS (Mitochondrial
antiviral signaling protein), a critical mitochondrial adaptor
required for IFN induction by the RLR pathway and appears
to inhibit the type I IFN production (Fig. 1) (Varga et al., 2011).
The 1918 pandemic inﬂuenza A/H1N1 and HPAI H5N1 are
considered to have this polymorphism that is correlated with
increased pathogenicity (Conenello et al., 2007).
PB1-F2 is not the only inﬂuenza viral protein that is found
in the mitochondria. PB2, one of the subunits of the viral
polymerase also can be found in mitochondria as well as in
nucleus (Carr et al., 2006). The later can inhibit the pro-
duction of type I IFN by interacting with MAVS similar to PB1-
F2 (Graef et al., 2010). Interaction of PB2 with MAVS can
also inhibit the IFN-β production and depends upon single
amino acid polymorphism, this can be found in seasonal
inﬂuenza viruses but not in highly pathogenic avian inﬂuenza
(HPAI) viruses (Iwai et al., 2010). Inﬂuenza viral strains with
highly efﬁcient polymerases can evade the IFN response
in vivo due to their frequent mutations occurred during





















Figure 2. JAK-STAT signaling pathway and its interaction with viral proteins. The auto- and paracrine actions of IFNs lead to
activation of JAK-STAT pathway and terminate into the formation of ISGF3. This transcription factor will initiate the transcription of
hundred of interferon stimulated genes (ISGs) containing interferon stimulated response element (ISRE). IAV proteins and IAV-
induced cellular proteins such as SOCS act as negative regulators of JAK-STAT signaling pathway.
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The M2 protein of inﬂuenza virus is a transmembrane protein
that is needed for proper uncoating of inﬂuenza virus
ribonucleoproteins (RNPs) during the viral entry process
(Pinto et al., 1992). M2 forms a selective ion channel for the
entry of viral protein. Recently, it has been observed that this
protein interferes with cellular autophagy (Gannage et al.,
2009). Autophagy participates in TLR activation during viral
infection. Thus, it is likely that M2 is able to prevent activation
of TLR. In addition, M2 protein also inhibits the P58IPK, a
cellular regulator of PKR that forms a complex with heat
shock protein 40 (hsp40) (Fig. 2), leading to the inhibition of
protein translation, activation of apoptosis pathway, and
escape of newly formed viral particles from host (Guan et al.,
2011).
Use of cellular proteins
Interestingly, inﬂuenza viruses not only use their own proteins
to evade the innate immune system, but also take advantage
of speciﬁc cellular regulators of immune system to further
minimize the antiviral effects by host cells. Recently, it has
been demonstrated that inﬂuenza virus-induced SOCS1
inhibits the phosphorylation of STAT1 at early stages of
infection (Wei et al., 2014). Strikingly, virus-induced SOCS
proteins are also involved in the inhibition of IFNs signaling
(Fig. 2) (Jia et al., 2010). Inﬂuenza virus inhibits the PKR
activity by interfering with cellular inhibitor of PKR. It has been
found that the viral NP dissociates the P58IPK from hsp40 and
minimizes the antiviral state of cell (Sharma et al., 2011). In
addition, inﬂuenza virus can exploit the intracellular trafﬁcking
regulator proteins, such as Rho family members, for intra-
cellular transport of its components. For example, it has been
known that infection with inﬂuenza virus signiﬁcantly down
regulates the ARHGAP21, an inhibitor of Cdc42 activation
and thereby activates Cdc42 signaling in infected cells.
Experimental studies have demonstrated that activated
Cdc42 is required for efﬁcient transport of inﬂuenza virus NA
toward the plasma membranes (Wang et al., 2012). While
cells with overexpression of ARHGAP21 showed reduced
concentration of NA at cell surface as compared to control,
disruption of ARHGAP21 expression facilitates the NA
transportation to the plasma membrane (Wang et al., 2012).
CONCLUSIONS
In last decade, our knowledge on innate immune responses
against inﬂuenza infections has expanded signiﬁcantly. As a
result, serious efforts were made to utilize the gained
knowledge for designing better vaccines and accompanying
control measures. While our understanding increased on the
virus-induced innate immunity, it remains to better under-
stand the dynamics and breadth of innate immunity in tissue,
species, and host-speciﬁc manners. Although more viral
proteins are being identiﬁed in the inﬂuenza viruses, their
importance in the inﬂuenza pathogenesis is not clearly elu-
cidated. In particular, little information is available about their
role in viral escape from host innate immunity. Bridging these
gaps will pave the ways not only for designing better vacci-
nes but also for developing novel antiviral agents.
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